Leukemia Clinical Trials in Salt Lake City

Showing 401-420 of 1,447 trials

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

NCT05643742

This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX112™ in subjects with relapsed or refractory B-cell malignancies.

B-cell LymphomaNon-Hodgkin LymphomaB-cell Malignancy+5 more

CRISPR Therapeutics AG120 participantsStarted Mar 2023

Westwood, Kansas, United States • St Louis, Missouri, United States • San Antonio, Texas, United States +4 more locations

RECRUITINGPhase 1/2< 1 mile

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT05379985

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors.

Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more

Revolution Medicines, Inc.754 participantsStarted May 2022

Orange, California, United States • Santa Monica, California, United States • Tampa, Florida, United States +13 more locations

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Leukemia Trials in Other Cities

Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers

ALTERRA Post-Approval Study

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

A Study of PF-06873600 in People With Cancer

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Functional Lumen Opening With Self-Forming Magnetic Anastomosis

A Trial Evaluating TG4050 in Ovarian Carcinoma.

Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia

Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

Other Conditions in Salt Lake City